Antiviral Drugs
Classification of viral infectionsHerpes simplex and varicella-zoster
Human immunodeficiency
Influenza A
Cytomegalovirus
Respiratory Syncytial virus (RSV)
Drugs that modulate the host immune system
Herpes simplex and varicella-zoster
AciclovirValaciclovir
famciclovir
Aciclovir
Mechanism of actionInhibits viral DNA synthesis only after phosphorylation by virus-specific thymidine kinase.
The phosphorylated aciclovir inhibits DNA polymerase in the virus and so prevents virus DNA formation
Aciclovir
It is effective against susceptible Herpes viruses if started early in the course of infection, but it does not eradicate persistent infection because viral DNA is integrated in the host genome.
Aciclovir
Clinical usesHerpes simplex virus
Skin infections, including initial and recurrent labial and genital herpes
Ocular keratitis
Encephalitis, disseminated disease (IV)
Aciclovir (clinical uses)
Varicella-zoster virusChickenpox, particularly in the immunocompromised (IV) or in the immunocompetent with pneumonitis or hepatitis (IV)
Shingles in immunocompetent persons
Aciclovir
Adverse effectsOphthalmic ointment causes a mild transient stinging sensation
gastrointestinal symptoms, headache, and neuropsychiatric reactions.
Human immunodeficiency
Nucleoside reverse transcriptase inhibitorsProtease inhibitors
Non- nucleoside reverse transcriptase inhibitors
Entry inhibitor
Nucleoside reverse transcriptase inhibitors
Zidovudine (Retrovir)
Didanosine
Lamivudine
Zidovudine (Retrovir)
Mechanism of actionHas a high affinity for HIV’s reverse transcriptase and is integrated by it into the viral DNA chain causing premature chain termination. The drug must be present continuously.
Zidovudine (Retrovir)
Clinical usesSerious manifestations of HIV infection in patients with acquired immunodeficiency syndrome or AIDs related complex
Zidovudine (Retrovir)
Adverse effectsAnorexia, nausea, vomiting, Headache, dizziness, Malaise and myalgia
Anemia and neutropenia
Hepatic necrosis
Protease inhibitors (amprenavir)
Mechanism of actionIn its process of replication, HIV produces protein and also a protease, which cleaves the protein into component parts that are subsequently reassembled into virus particles; protease inhibitors disrupt this essential process
Protease inhibitors
Adverse effects
GIT disturbance, headache, dizziness, sleep disturbance, pancreatitis, neutropenia, and rashes.
Non-nucleoside reverse transcriptase
Used in africa HIV1Efavirenz
Entry inhibitor
Enfuvirtideis the first antiretroviral agent to target the host cell attachment/entry stage in the HIV replicaton cycle.
Influenza A
AmantadineZanamivir
Oseltamivir (Tamiflu)
Amantadine
Is only effective only against influenza A; it acts by interfering with the uncoating and release of viral genome into the host cell.Amantadine
Clinical UsesUsed orally for the prevention and treatment of infection with influenza A virus
Adverse effects
Dizziness, nervousness, and insomnia
Zanamivir
Is a viral neuraminidase inhibitor that blocks both entry of influenza A and B viruses to target cells.Oseltamivir (Tamiflu)
Is an oral pro-drug of a viral neuraminidase inhibitor. it reduces the severity and duration of symptoms caused by influenza A or BIs one option for treatment and prophylaxis of avian H5N1 influenza
Cytomegalovirus
GanciclovirResembles aciclovir in its mode of action, but is much more toxic
Respiratory syncytial virus (RSV)
Ribavirin is a synthetic nucleoside used for RSV bronchiolitis in infants and children, inhaled by a special ventilator.Drugs that modulate the host immune system
InterferonsDirectly on uninfected cells to induce enzymes that degrade viral RNA
Indirectly by stimulating the immune system
To modify cell regulator mechanisms and inhibit neoplastic growth
Drugs that modulate the host immune system
Interferons
Interferons are cassified as alfa, beta, gamma according to their antigenic and physical properties.
Interferon alfa 2 a and 2b also improve the manifestations of viral hepatitis.
Adverse effects
Are common and include an influenza-like syndrome
Drugs that modulate the host immune system
Imiquimodis used topically for genital warts (caused by papillomaviruses). Treatment for 2-3 months results in gradual clearance of warts in about 50% patients.